Levo Therapeutics, Inc.
1 clinical trials · Sponsor
◉ Watch Levo Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Phase 3 Study of Intranasal Carbetocin (LV-101) in Patients With Prader-Willi Syndrome (NCT03649477) | Levo Therapeutics, Inc. | 2018-11-20 |
Track Levo Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.